What is MapLight Therapeutics, Inc. 's market capitalization?

MapLight Therapeutics, Inc. (MPLT) reported market capitalization of $862.73M in Q1 2026.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

MapLight Therapeutics, Inc. MPLT Market capitalization

Market capitalization at other companies

Bristol-Myers SquibbBMY

$123.83B-0.2%

Johnson & JohnsonJNJ

$588.76B+47.3%

Neurocrine BiosciencesNBIX

$13.22B+19.9%

Acadia PharmaceuticalsACAD

$3.8B+37.0%

AbbVieABBV

$384.69B+3.8%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$707.12M—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Computed from the period-end share price: $862.73M.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's market capitalization?: MapLight Therapeutics, Inc. (MPLT) reported market capitalization of $862.73M in Q1 2026.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.